Latest in Pharmaceutical

Reckitt expands US OTC manufacturing footprint with North Carolina facility

The site in Wilson will be responsible for producing Mucinex® branded tablets and liquids, which are designed as over the counter (OTC) medicines for cold and flu symptoms

Find out more

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space,...
See more

AstraZeneca's Imfinzi gains FDA approval for limited-stage small cell lung cancer

The immunotherapy has been approved based on the results of the Phase III ADRIATIC clinical trial, which evaluated the benefits of durvalumab in patients with limited-stage SCLC

Merck's sacituzumab tirumotecan granted Breakthrough Therapy Designation by the FDA

The antibody-drug conjugate (ADC) can be used to treat patients with advanced or metastatic non-small cell lung cancer (NSCLC)

Sigrid Therapeutics' blood glucose-lowering silica, SiPore, attains US patent

The silica-based gel, when taken alongside a meal, can reduce blood glucose levels and reduce the risk of a user developing metabolic syndrome and other obesity-related complications

Ipsen licenses Biomunex Pharmaceuticals' bispecific antibody, BMX-502

The deal makes Biomunex eligible for up to $610m, with Ipsen being responsible for getting the cancer immunotherapy into Phase I clinical trials

Gerresheimer begins €100m expansion of its pharmaceutical syringe production capabilities

The extension of its Skopje, North Macedonia site will allow Gerresheimer to better serve the pharmaceutical and biotech industries
You need to be a subscriber to read this article.
Click here to find out more.

The new fight against diabetes and obesity

Incretin mimetics administered by autoinjectors or pens enable significant weight reduction and offer an important way to combat obesity and prevent type 2 diabetes. As such, pharmaceutical manufacturers are currently investing heavily in development and production

Innovating primary packaging for parenteral drugs: challenges and future directions

The new challenges brought about by the pandemic call for an increasingly scientific approach to the evolution of single packaging elements in order to anticipate the needs of new drug formulations and guarantee a more enhanced, measurable and stable level of performance

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

Latest posts in Pharmaceutical

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics

Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China

The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format

Syndax Pharmaceuticals' leukaemia drug Revuforj bags FDA approval

The therapeutic is the first and only menin inhibitor to gain FDA approval for acute relapsed or refractory acute leukaemia

Transmission Raman Spectroscopy - access the webinar series today

Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series

AbbVie's Elahere approved for platinum-resistant ovarian cancer by the European Commission

Elahere is the first FRα-targeting antibody-drug conjugate (ADC) to be approved in Europe for platinum-resistant ovarian cancer

Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines

The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

Syncona launches early-stage drug development company, Slingshot Therapeutics

The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease

Accord Healthcare bolsters UK drug manufacturing capabilities with £50m Newcastle facility

The novel automated facility will allow Accord to produce therapeutics for oncological and autoimmune diseases for the UK and beyond

Novartis obtains FDA approval for CML drug, Scemblix

The TKI's approval is an important step forward for oncology patients with newly diagnosed chronic myeloid leukaemia, and was based on the results of the Phase III ASC4FIRST trial

Sponsor content

IMA Life announces strategic partnership with RheaVita to drive further technological development and commercial growth

IMA Life makes a strategic investment in RheaVita and will support the company in advancing and commercialising its breakthrough continuous freeze-drying technology for...

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality...

Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies

Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades

The importance of accurate tare/gross weighing systems in the pharmaceutical industry

Why accurate tare/gross weighing is critical in pharmaceutical settings

CPHI Milan survey 'faster CDMO growth in 2025 predicted' and 'industry not in favour of BIOSECURE Act'

49% of industry is ‘highly positive’ on contract services growth in the next 18-months

CPHI Milan analysis ‘Lombardy the best location for pharma manufacturing in Europe’

Report predicts significant growth for Lombardy’s pharma industry in 2025 as event directly contributes more than €120m to region

Biotech Capital on the rise and outsourcing to accelerate in 2025 - but uneven growth for CDMOs

European biotech recovery gains momentum as Chinese biotech declines, and IPO activity remains weak

IMA showcases pharmaceutical innovations at CPHI, Milan

Aseptic processing, continuous manufacturing, and sustainable packaging at the forefront

Thermo Fisher scientific launches iCAP MX series ICP-MS for trace elemental analysis

New platform simplifies analysis while enhancing productivity and accuracy

Sphere Fluidics unveils Cyto-Mine Chroma to enhance single-cell analysis

New platform offers multiplexing capabilities and accelerates biotherapeutic discovery and development

Marchesini Group celebrates 50 years of innovation at CPHI 2024

Showcasing a new cartoning machine model and the latest digital division technologies

Ensuring cGMP compliance in cell and gene therapy manufacturing

3P discusses how companies can scale up their CGT manufacturing protocols while remaining compliant with stringent global regulations

Featured companies

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life... 3P innovation is a UK-based engineering and custom automation company, delivering innovative solutions to leading major pharmaceutical and medical device companies. We support...
See more